You're Invited! Join #AlconGlobalMedicalAffairs to learn About Acoltremon Ophthalmic Solution 0.003%, a Novel Drug Candidate for #DryEyeDisease at #SECO2025.
Alcon Science
Medical Equipment Manufacturing
Learn about the science behind innovations from Alcon. This channel is intended for US Based HCPs only.
About us
Learn about the science behind innovations from Alcon. This channel is intended for US Based HCPs only.
- Website
-
https://www.alconscience.com
External link for Alcon Science
- Industry
- Medical Equipment Manufacturing
- Company size
- 10,001+ employees
Updates
-
In a recent study, 25 dry eye patients who get 6+ hours of screen time per day received SYSTANE® COMPLETE twice daily. After 3 months, average Ocular Surface Disease Index fell from 21.5 to 14.4, and average tear osmolarity fell from ~285 to ~279. Learn more: https://bit.ly/4iNieBm #Ophthalmology
-
Dr. Matthew Rauen outlines a study evaluating the impact of maintaining high intraocular pressure (IOP) versus near-physiologic IOP during the phacoemulsification step of cataract surgery. See the full video here: https://bit.ly/49O9hUl #Ophthalmology #Alcon #AlconInnovation #cataractsurgery
-
Here, Dr. Eric Rosenberg discusses a study comparing recovery time and adverse outcomes after cataract surgery using the NGENUITY® 3D Visualization System versus a traditional ophthalmic microscope. See the full video here: https://bit.ly/4gnbKHN #Ophthalmology #AlconInnovation
-
Join #AlconGlobalMedicalAffairs for breakfast at #SECO2025! Learn more about the results from the phase 4 multi-center, open-label #Rocklatan evaluation (MORE) study for the treatment of #Glaucoma.
-
-
You're Invited! Join #AlconGlobalMedicalAffairs to learn About Acoltremon Ophthalmic Solution 0.003%, a Novel Drug Candidate for #DryEyeDisease at #SECO2025.
-
-
Click to view the recently published manuscript on the ROCKLATAN® Phase 4 MORE Study and learn about the Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: https://bit.ly/42RBVT3
-
-
“We observed faster visual recovery and lower rates of cystoid macular edema in eyes that underwent cataract surgery using the NGENUITY® 3D Visualization System, and these findings were even more profound in diabetic eyes.” — Dr. Eric Rosenberg | Watch Dr. Rosenberg review the latest findings: https://bit.ly/4gnbKHN
-
-
Join #Alcon in Kauai on Jan 19 for #HawaiianEyeandRetina 2025! Our lunchtime session explores acoltremon ophthalmic solution 0.003% for #DryEye & the results of the COMET pivotal trials. See you there! #Alcon #DryEye
-
-
Attending #HawaiianEyeandRetina 2025? Attend our lunchtime session to learn more about the phase 3 pivotal trial data for acoltremon ophthalmic solution 0.003%, a novel drug candidate for dry eye disease. For more information on #DryEye, visit AlconScience: https://bit.ly/4dLtZVh #Alcon #DryEye #HawaiianEyeandRetina
-